These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 1966784

  • 1. Protective action of blood ceruloplasmin obtained from normal individuals on red blood cells compared with that from patients with Wilson's disease.
    Saenko EL, Skorobogat'ko OV, Yaropolov AI.
    Biomed Sci; 1990; 1(5):453-9. PubMed ID: 1966784
    [Abstract] [Full Text] [Related]

  • 2. The protective effect of normal and pathological (Wilson disease) ceruloplasmins on human erythrocytes.
    Saenko EL, Skorobogat'ko OV, Yaropolov AI.
    Biochem Int; 1990; 20(3):463-9. PubMed ID: 2161227
    [Abstract] [Full Text] [Related]

  • 3. [Comparison of the protective effects on the erythrocytes of ceruloplasmin from the blood of healthy donors and patients with hepatocerebral dystrophy].
    Saenko EL, Skorobagat'ko OV, Iaropolov AI.
    Biull Eksp Biol Med; 1990 Oct; 110(10):368-70. PubMed ID: 2279084
    [Abstract] [Full Text] [Related]

  • 4. Interrelation between structure and protective action of normal and pathological ceruloplasmins during copper-induced lysis of red blood cells.
    Saenko EL, Skorobogat'ko OV, Yaropolov AI.
    Biochem Int; 1990 Nov; 22(4):749-57. PubMed ID: 1964048
    [Abstract] [Full Text] [Related]

  • 5. The protective effect of different forms of human ceruloplasmin in copper-induced lysis of red blood cells.
    Saenko EL, Yaropolov AI.
    Biochem Int; 1990 Oct; 22(1):57-66. PubMed ID: 2282081
    [Abstract] [Full Text] [Related]

  • 6. Molecular forms of ceruloplasmin in hepatolenticular degeneration and their interaction with human erythrocyte ceruloplasmin receptor.
    Puchkova LV, Verbina IA, Denezhkina VV, Vakharlovskii VG, Voitsekhovskii BL, Gaitskhoki VS, Neifakh SA.
    Biomed Sci; 1990 Oct; 1(5):460-6. PubMed ID: 1966785
    [Abstract] [Full Text] [Related]

  • 7. [Interconnection between the structure and protective action of normal and pathological ceruloplasmin preparations in copper-induced erythrocyte lysis].
    Saenko EL, Skorobogat'ko OV, Iaropolov AI.
    Biokhimiia; 1991 May; 56(5):820-7. PubMed ID: 1747411
    [Abstract] [Full Text] [Related]

  • 8. [Interaction of molecular forms of ceruloplasmin with specific membrane receptors from healthy persons and patients with hepatolenticular degeneration].
    Puchkova LV, Verbina IA, Gaĭtskoki VS, Neĭfakh SA.
    Biokhimiia; 1991 Dec; 56(12):2261-9. PubMed ID: 1666959
    [Abstract] [Full Text] [Related]

  • 9. [Protective effect rendered by human ceruloplasmin on erythrocytes in hepatocerebral dystrophy].
    Saenko EL, Skorobogat'ko OV, Mzhel'skaia TI, Ivanova-Smolenskaia IA, Markova ED, Basevich VV.
    Biokhimiia; 1989 Oct; 54(10):1617-22. PubMed ID: 2605268
    [Abstract] [Full Text] [Related]

  • 10. Studies on receptor interaction of ceruloplasmin with human red blood cells.
    Saenko EL, Yaropolov AI.
    Biochem Int; 1990 Oct; 20(2):215-25. PubMed ID: 2156504
    [Abstract] [Full Text] [Related]

  • 11. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T, Tirouche YD, Abaoub-Germain A, Theodore F.
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [Abstract] [Full Text] [Related]

  • 12. [Characteristics of ceruloplasmin interaction with a specific receptor of human erythrocytes].
    Saenko EL, Basevich VV, Iaropolov AI.
    Biokhimiia; 1988 Feb; 53(2):317-21. PubMed ID: 2835996
    [Abstract] [Full Text] [Related]

  • 13. Serum ceruloplasmin oxidase activity is a sensitive and highly specific diagnostic marker for Wilson's disease.
    Merle U, Eisenbach C, Weiss KH, Tuma S, Stremmel W.
    J Hepatol; 2009 Nov; 51(5):925-30. PubMed ID: 19720421
    [Abstract] [Full Text] [Related]

  • 14. Wilson's disease patients with normal ceruloplasmin levels.
    Yüce A, Koçak N, Ozen H, Gürakan F.
    Turk J Pediatr; 1999 Nov; 41(1):99-102. PubMed ID: 10770682
    [Abstract] [Full Text] [Related]

  • 15. Reconstitution of the intercellular transfer pathway of the peptide moiety of ceruloplasmin in mammals.
    Puchkova LV, Sasina LK, Aleinikova TD, Zakharova ET, Gaitskhoki VS.
    Biochemistry (Mosc); 1997 Jul; 62(7):697-703. PubMed ID: 9331961
    [Abstract] [Full Text] [Related]

  • 16. A critical evaluation of copper metabolism in Indian Wilson's disease children with special reference to their phenotypes and relatives.
    Prasad R, Kaur G, Walia BN.
    Biol Trace Elem Res; 1998 Nov; 65(2):153-65. PubMed ID: 9881519
    [Abstract] [Full Text] [Related]

  • 17. [Protective effect of various forms of human ceruloplasmin in copper-induced erythrocyte lysis].
    Saenko EL, Iaropolov AI.
    Biokhimiia; 1991 Apr; 56(4):648-54. PubMed ID: 1655069
    [Abstract] [Full Text] [Related]

  • 18. Value of an enzymatic assay for the determination of serum ceruloplasmin.
    Macintyre G, Gutfreund KS, Martin WR, Camicioli R, Cox DW.
    J Lab Clin Med; 2004 Dec; 144(6):294-301. PubMed ID: 15614251
    [Abstract] [Full Text] [Related]

  • 19. Identification of apo- and holo-forms of ceruloplasmin in patients with Wilson's disease using native polyacrylamide gel electrophoresis.
    Hirano K, Ogihara T, Ogihara H, Hiroi M, Hasegawa M, Tamai H.
    Clin Biochem; 2005 Jan; 38(1):9-12. PubMed ID: 15607310
    [Abstract] [Full Text] [Related]

  • 20. [Metabolism of ceruloplasmin and copper in the blood in Wilson's disease].
    Kanai M, Nomoto S, Tsukagoshi H, Shindo M.
    Rinsho Byori; 1974 Oct; 22(10 Suppl):191. PubMed ID: 4475793
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.